Safety and efficacy of Bacillus&#160;subtilis DSM&#160;28343 as a feed additive for chickens for fattening by G. Aquilina et al.
SCIENTIFIC OPINION
ADOPTED: 24 May 2016
doi: 10.2903/j.efsa.2016.4507
Safety and efﬁcacy of Bacillus subtilis DSM 28343 as a
feed additive for chickens for fattening
EFSA Panel on Additives and Products or Substances used in
Animal Feed (FEEDAP)
Abstract
The additive is a preparation containing viable spores of a strain of Bacillus subtilis which has never
been authorised in the EU. It is intended to be used in feeds for chickens for fattening at the
recommended dose of 1 9 109 colony-forming unit (CFU)/kg complete feedingstuffs. The bacterial
species B. subtilis is considered by EFSA to be suitable for the qualiﬁed presumption of safety
approach to safety assessment. As the identity of the active agent has been established and the
susceptibility to antibiotics and lack of toxigenic potential have been demonstrated, the use of
Bacillus subtilis DSM 28343 can be presumed safe for the target species, consumers of products
derived from animals fed the additive and the environment. Bacillus subtilis DSM 28343 is not an eye/
skin irritant but should be considered as a potential respiratory sensitiser. In the absence of data, no
conclusion can be drawn on the skin sensitisation potential. Bacillus subtilis DSM 28343 at the
proposed dose has the potential to be efﬁcacious in improving growth of chickens for fattening.
B. subtilis DSM 28343 is compatible with the coccidiostats lasalocid A sodium, diclazuril, monensin
sodium, maduramicin ammonium, decoquinate, nicarbazin, robenidine hydrochloride and halofuginone
hydrobromide.
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1. Introduction
1.1. Background and Terms of Reference
Regulation (EC) No 1831/20031 establishes the rules governing the Community authorisation of
additives for use in animal nutrition. In particular, Article 4(1) of that Regulation lays down that any
person seeking authorisation for a feed additive or for a new use of a feed additive shall submit an
application in accordance with Article 7.
The European Commission received a request from Lactosan GmbH & Co. KG.2 for authorisation of
the product Bacillus subtilis DSM 28343 (Bacillus subtilis DSM 28343), when used as a feed additive for
chickens for fattening (category: Zootechnical additives; functional group: gut ﬂora stabilisers).
According to Article 7(1) of Regulation (EC) No 1831/2003, the Commission forwarded to the
European Food Safety Authority (EFSA) an application under Article 4(1) (authorisation of a feed
additive or new use of a feed additive). EFSA received directly from the applicant the technical dossiers
in support of this application. The particulars and documents in support of the application were
considered valid by EFSA as of 24 April 2015.
According to Article 8 of Regulation (EC) No 1831/2003, EFSA, after verifying the particulars and
documents submitted by the applicant, shall undertake an assessment in order to determine whether
the feed additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on
the safety for the target animals, consumer, user and the environment and on the efﬁcacy of the
product Bacillus subtilis DSM 28343 (Bacillus subtilis DSM 28343), when used under the proposed
conditions of use (see Section 3.1.5).
1.2. Additional information
The additive Bacillus subtilis DSM 28343 is a preparation containing viable spores of a strain of
Bacillus subtilis. This additive has never been authorised in the European Union (EU).
The species Bacillus subtilis is considered by EFSA to be suitable for the qualiﬁed presumption of
safety (QPS) approach to safety assessment (EFSA, 2007; EFSA BIOHAZ Panel, 2013). This approach
requires the identity of the strain to be conclusively established, evidence that the strain is not
toxigenic and that it does not show resistance to antibiotics of human and veterinary importance.
2. Data and methodologies
2.1. Data
The present assessment is based on data submitted by the applicant in the form of a technical
dossier3 in support of the authorisation request for the use of Bacillus subtilis DSM 28343 as a feed
additive. The technical dossier was prepared following the provisions of Article 7 of Regulation (EC)
No 1831/2003, Regulation (EC) No 429/20084 and the applicable EFSA guidance documents.
EFSA has veriﬁed the European Union Reference Laboratory (EURL) report as it relates to the
methods used for the control of the active agent in animal feed. The Executive Summary of the EURL
report can be found in Annex A.
2.2. Methodologies
The approach followed by the Panel on Additives and Products or Substances used in Animal Feed
(FEEDAP) to assess the safety and the efﬁcacy of Bacillus subtilis DSM 28343 is in line with the principles
laid down in Regulation (EC) No 429/20084 and the relevant guidance documents: Guidance on
zootechnical additives (EFSA FEEDAP Panel, 2012a), Technical guidance: Tolerance and efﬁcacy studies
in target animals (EFSA FEEDAP Panel, 2011), Guidance on studies concerning the safety of use of the
additive for users/workers (EFSA FEEDAP Panel, 2012b), Guidance on the assessment of the toxigenic
potential of Bacillus species used in animal nutrition (EFSA FEEDAP Panel, 2014), Technical guidance –
1 Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in
animal nutrition. OJ L 268, 18.10.2003, p. 29.
2 Lactosan GmbH & Co. KG, Industriestrasse West 5, 8605, Kapfenberg, AT.
3 FEED dossier reference: FAD-2015-0006.
4 Commission Regulation (EC) No 429/2008 of 25 April 2008 on detailed rules for the implementation of Regulation (EC)
No 1831/2003 of the European Parliament and of the Council as regards the preparation and the presentation of applications
and the assessment and the authorisation of feed additives. OJ L 133, 22.5.2008, p. 1.
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Update of the criteria used in the assessment of bacterial resistance to antibiotics of human or veterinary
importance (EFSA FEEDAP Panel, 2012c), and Technical guidance on the compatibility of zootechnical
microbial additives with other additives showing antimicrobial activity (EFSA FEEDAP Panel, 2008).
3. Assessment
The additive is a preparation containing viable spores of a strain of B. subtilis. It is intended to be
authorised as a zootechnical additive (functional group: gut ﬂora stabilisers) in diets for chickens for
fattening.
3.1. Characterisation
3.1.1. Characterisation of active agent
The Bacillus subtilis strain was isolated from hay and has been deposited in the Deutsche
Sammlung von Mikroorganismen und Zellkulturen with the accession number DSM 28343.5 The strain
has not been genetically modiﬁed.
Taxonomical identiﬁcation of the product strain as B. subtilis was achieved by the sequence analysis
of gyrA and 16S rRNA genes.6 Strain-speciﬁc identiﬁcation is based on the use of pulsed-ﬁeld gel
electrophoresis and genetic stability analysis was demonstrated by comparing the random ampliﬁed
polymorphic DNA patterns of the deposited culture (master cell bank) with those of the working cell
bank and of the cultures deriving from three different production batches.7
Cytotoxicity tests were performed using Vero cells and the 10-fold methanol or ammonium sulfate
concentrated supernatants.8 As no cytotoxic effect on Vero cells was detected, the strain is considered
to be non-toxigenic.
Bacillus subtilis DSM 28343 was tested for antibiotic susceptibility using twofold broth dilutions.9
The battery of antibiotics tested was that recommended by EFSA (EFSA FEEDAP Panel, 2012c). All
minimum inhibitory concentration (MIC) values were equal or fell below the corresponding cut-off
values deﬁned by the FEEDAP Panel, and thus, no further investigation is needed.
3.1.2. Characterisation of the additive
The additive is described as a solid, free-ﬂowing granulated product with a minimum content of
spores of Bacillus subtilis DSM 28343 of 1 9 1010 colony-forming unit (CFU)/g. The carrier materials
include calcium carbonate (93–95%), maltodextrins (2%) and silicon dioxide (1%).
Data on 10 batches of the additive showed that the minimum speciﬁcation was slightly exceeded in
all cases (mean value 1.3 9 1010 CFU/g, range 1.2–1.5 9 1010 CFU/g).10
The additive is routinely monitored for microbial contamination at various points in the
manufacturing process and in the ﬁnal product. Analyses of three batches of the additive
demonstrated compliance with the limits for Enterobacteriaceae (< 1,000 CFU/g), yeasts and
ﬁlamentous fungi (< 1,000 CFU/g) and Salmonella (absent in 25 g).11 The applicant claims that as raw
materials used in the fermentation process are food and feed grade, no contamination with
mycotoxins, heavy metals or arsenic is expected and no monitoring is carried out. To support this
claim, three batches of the additive were tested for aﬂatoxin B1, aﬂatoxin B2, aﬂatoxin G1, aﬂatoxin
G2, zearalenone, deoxynivalenol, lead, cadmium, mercury and arsenic.12 None of the mycotoxins were
detected.13 Lead showed a range of 0.42–0.53 mg/kg, arsenic of 0.28–0.32 mg/kg and cadmium and
mercury showed values below the limit of quantiﬁcation.14 None of these concentrations give rise to
concerns.
5 Technical dossier/Section II/Annex II.2-1.
6 Technical dossier/Section II/ Annexes II.2-2 and 3.
7 Technical dossier/Section II/Annex II.2-4.
8 Technical dossier/Section II/Annex II.2-5.
9 Technical dossier/Section II/Annex II.2-6.
10 Technical dossier/Section II/Annex II.1-2.
11 Technical dossier/Section II/Annex II.1-3.
12 Technical dossier/Section II/Annexes II.1-4 and II.1-5.
13 Limits of detection: aﬂatoxin B1 < 0.03 µg/kg, aﬂatoxin B2 < 0.03 µg/kg, aﬂatoxin G1 < 0.03 µg/kg, aﬂatoxin G2 < 0.03 µg/kg,
zearalenone < 0.005 mg/kg and deoxyvalenol < 0.01 mg/kg.
14 Limits of quantiﬁcation: cadmium < 0.20 mg/kg and mercury < 0.050 mg/kg.
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One batch of Bacillus subtilis DSM 28343 was examined for particle size distribution by a laser
diffraction and dusting potential with a Heubach dustometer.15 Results showed that 9% by volume of
the additive consists of particles with diameters below 50 lm and the same percentage of particles
with diameters below 10 lm and that the dusting potential of the additive is 0.4 g/m3.
3.1.3. Production process
The active agent is produced by fermentation using an industrial culture medium containing yeast
extract and salts.16 After sporulation, the fermentation broth is centrifuged in order to concentrate the
cell mass and the resulting slurry is mixed with maltodextrins and spray-dried. After drying, the spores
are mixed in the appropriate proportion and blended with excipients (calcium carbonate and silicon
dioxide).
3.1.4. Stability and homogeneity
For the purpose of testing shelf-life, three batches of the additive were stored at 20°C for
12 months and at 37°C for 6 months.17 Bacterial counts demonstrated the stability of the product over
this period.
Stability of three batches of Bacillus subtilis DSM 28343 was tested when mixed with a mineral
premixture and a minerals/vitamins premixture, and with mash and pelleted feed for chickens for
fattening, and stored at 20°C for 6 and 3 months, respectively.18 No signiﬁcant differences were
observed in the bacterial counts over these periods.
The stability to pelleting of a single batch of the additive when mixed with chickens feed was tested
in triplicate at different temperatures (60, 70 and 80°C).19 The enumeration of bacilli spores showed a
recovery close to 90% or higher after the thermal treatment.
The ability of the additive to be uniformly distributed was examined using a single batch of the
additive mixed into a pelleted feed for chickens.19 Analyses of bacterial counts of 10 subsamples
showed a coefﬁcient of variation of 11%.
3.1.5. Conditions of use
The product is intended for use in feed for chickens for fattening at a minimum dose of
1 9 109 CFU/kg complete feedingstuffs.
The applicant claims that the additive can be used in poultry feed in conjunction with coccidiostats.
3.2. Safety
The species B. subtilis is considered by EFSA to be suitable for the QPS approach to safety
assessment (EFSA, 2007; EFSA BIOHAZ Panel, 2013). In the view of the FEEDAP Panel, the identity of
the Bacillus subtilis DSM 28343 is established and the toxigenic potential and the antibiotic resistance
qualiﬁcations have been met. Therefore it is presumed safe for the target species, consumer and the
environment.
3.2.1. Safety for the user
A study of acute dermal irritation with Bacillus subtilis DSM 28343 was performed following a
protocol that conformed to Organisation for Economic Co-operation and Development (OECD)
Guideline 404.20 No reactions were seen in any of the animals after 72 h; thus, it is concluded that the
additive is not a skin irritant.
A study of acute eye irritation with Bacillus subtilis DSM 28343 was performed using three male
New Zealand White rabbits and following a protocol that conformed to OECD Guideline 405.21 The test
item produced a slight conjunctival redness in two animals and a chemosis in one animal that were
15 Technical dossier/Section II/Annexes II.1-6–II.1-8.
16 Technical dossier/Section II/Annexes II.3-1 and II.3-2.
17 Technical dossier/Section II/Annex II.4-1.
18 Technical dossier/Section II/Annex II.4-3.
19 Technical dossier/Section II/Annex II.4-4.
20 Technical dossier/Section III/ Annex III.3.4.
21 Technical dossier/Section III/ Annex III.3-5.
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fully reversible within 1 day. A slight opacity was also observed in the cornea of one animal, totally
reversible within 2 days. Overall results indicate that the additive is not an eye irritant.
Skin sensitisation potential was not studied. Therefore, in the absence of data, no conclusion can
be drawn on the skin sensitisation potential.
A small fraction (9%) of the particles of the product has the potential to reach the respiratory
surface of the lungs when inhaled. Given the proteinaceous nature of the active agent, the additive
should be considered to be a potential respiratory sensitiser.
3.2.1.1. Conclusions on safety for the user
Bacillus subtilis DSM 28343 is not an eye/skin irritant but should be considered as a potential respiratory
sensitiser. In the absence of data, no conclusion can be drawn on the skin sensitisation potential.
3.3. Efﬁcacy
3.3.1. Efﬁcacy for chickens for fattening
Five efﬁcacy studies lasting 35 days were performed in two Member States to demonstrate the
efﬁcacy of Bacillus subtilis DSM 28343 in improving performance of chickens for fattening. In all
studies, a control group was compared with a group receiving the same basal diet supplemented with
the additive at the minimum recommended dose (1 9 109 CFU/kg complete feedingstuffs).
The ﬁrst study involved 2,240 one-day-old chickens (Ross 308, 50% females and 50% males)
allocated to two groups (control and treatment). The treatment group received the additive at the
recommended level (dose conﬁrmed by analysis).22 Each treatment was replicated eight times with
140 birds per replicate (Table 1). Birds were fed ad libitum diets based on maize, wheat and soybean
according to the production stage (starter, grower and ﬁnisher). Weight was recorded on days 1 (per
pen), 14, 24 and 35 (individually). Feed intake per pen was determined on days 14, 24 and 35, and
feed to gain ratio (per pen) was calculated. Mortality was monitored daily. Data were subjected to
one-way analysis of variance (ANOVA). The pen was the experimental unit for all parameters.
Mortality was in average 1.6% and not treatment related. Final weight, weight gain and feed to
gain ratio were not inﬂuenced by treatment (Table 1).
The second study involved 240 male one-day-old chickens (Cobb 500) distributed in two groups
(control and treatment). The treated group received the additive at the minimum recommended level
(conﬁrmed by analysis).23 Birds within each group were randomly allocated to six pens of 20 animals
each (Table 1). The trial was divided in two feeding periods, starter (1–14 days) and grower
(15–35 days). Birds were fed maize/wheat/soybean meal diets (in mash form) provided ad libitum
Table 1: Summary of performance data of chickens for fattening receiving Bacillus subtilis
DSM 28343
N°
Total animals
(Replicates/
treatment 3 animals/
replicate)
Bacillus subtilis
DSM 28343
(CFU/kg feed)
Feed
intake
(g/day)
Final
weight
(kg)
Weight
gain
(g/day)
Feed:
gain
Mortality
(%)
1 2,240
8 9 140
0
1.0 9 109
92.6
94.9
2.00
2.03
55.8
56.7
1.61
1.63
2.0
1.2
2 240
6 9 20
0
1.0 9 109
94.4
94.5
2.17a
2.24b
60.8a
62.7b
1.55a
1.51b
2.5
1.7
3 224
6 9 18/19
0
1.0 9 109
93.0
94.6
2.19
2.24
61.4
62.9
1.54
1.53
2.7
0.9
4 241
6 9 20/21
0
1.0 9 109
95.6
99.7
2.20a
2.28b
61.7a
63.9b
1.56
1.56
0
0
5 657
16 9 20/21
0
1.0 9 109
94.7a
98.5b
2.14a
2.18b
61.0a
62.4b
1.57
1.59
4.3
2.4
CFU: colony-forming unit.
a, b: Means within a trial with a different superscript letters are signiﬁcantly different (p ≤ 0.05).
22 Technical dossier/Section IV/Annexes IV.1–IV.4.
23 Technical dossier/Section IV/Annexes IV.5 and IV.6.
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during the whole experimental period. Performance of birds was assessed by recording live weight,
feed intake and mortality per pen at the start and end of the trial. Data on ﬁnal weight and weight
gain were subjected to one-way ANOVA, whereas for feed to gain ratio a Student t-test was used. The
pen was the experimental unit for all parameters, giving six replicates per treatment.
Mortality was low (average 2.1%) and not treatment related. At the end of the experimental
period, birds receiving the additive at the minimum recommended dose showed a signiﬁcantly better
growth rate and feed to gain ratio than birds in the control group (Table 1).
The third24 and fourth25 studies were conducted in the same location and shared an identical
experimental design. In both studies, male one-day-old chickens (Ross 308) were distributed in two
groups (control and treatment). The treated group received the additive at the minimum
recommended level (conﬁrmed by analysis). In study 3, 224 birds (112 per treatment group) were
randomly allocated to 12 pens (six per treatment group) of 18/19 chickens. In study 4, 241 birds (121
in the control and 120 in the treated group) were randomly allocated to 12 pens (six per treatment
group) of 20/21 chickens (Table 1). Birds were fed soybean meal/maize/wheat-pelleted diets, provided
ad libitum for the entire duration of the study. Individual body weight was determined on days 0, 14
and 35, whereas feed intake per pen was recorded on a weekly basis. Data on ﬁnal weight and weight
gain were subjected to one-way ANOVA, whereas for feed to gain ratio a Student t-test was used. The
pen was the experimental unit for all parameters, giving six replicates per treatment.
No mortality occurred in study 4, while in study 3 it was low (average 1.8%). At the end of the
experimental period, birds receiving the additive at the minimum recommended dose showed a greater
weight and weight gain than birds in the control, but these differences were signiﬁcant only in study 4
(Table 1).
The last study involved 657 one-day-old chickens (Ross 308, 50% females and 50% males)
distributed in two groups (control and treatment). The treated group received the additive at the
minimum recommended level (conﬁrmed by analysis of feed).26 Birds within each group were
randomly allocated to 32 pens of 20/21 animals each (Table 1). The trial was divided in two feeding
periods, starter (1–14 days) and grower (15–35 days). Birds were fed soya/maize/wheat/soybean oil
diets (in mash form) provided ad libitum during the whole experimental period. Individual live weight
was recorded at start, on day 14 and at the end, and feed intake per pen was recorded weekly. Data
on ﬁnal weight and weight gain were subjected to one-way ANOVA, whereas for feed to gain ratio a
Student t-test was used. The pen was the experimental unit for all parameters.
Mortality rate was low in both groups (average 3.4%). Feed intake, ﬁnal weight and weight gain
were signiﬁcantly increased in the treated group compared with the control.
3.3.2. Compatibility with coccidiostats
An in vitro study in compliance with the Technical guidance on the compatibility of zootechnical
microbial additives with other additives showing antimicrobial activity (EFSA FEEDAP Panel, 2008) was
conducted with lasalocid A sodium, diclazuril, monensin sodium, maduramicin ammonium,
decoquinate, narasin/nicarbazin, narasin, nicarbazin, robenidine hydrochloride, salinomycin sodium and
halofuginone hydrobromide. All coccidiostats were used at the corresponding maximum authorised
dose.
As the MIC values of the coccidiostats were four times higher than the corresponding maximum
authorised dose, B. subtilis 28343 is considered to be compatible with lasalocid A sodium, diclazuril,
monensin sodium, maduramicin ammonium, decoquinate, nicarbazin, robenidine hydrochloride, and
halofuginone hydrobromide. The MICs of narasin/nicarbazin, narasin and salinomycin were smaller
than four times the corresponding maximum authorised dose. Therefore, compatibility with these
coccidiostats could not be established.
3.3.3. Conclusions on efﬁcacy for the target species
In three out of the ﬁve studies provided, the supplementation of Bacillus subtilis DSM 28343 at the
minimum recommended dose improved the growth of chickens for fattening.
24 Technical dossier/Section IV/Annexes IV-7–IV-10.
25 Technical dossier/Section IV/Annexes IV-11–IV-14.
26 Technical dossier/Supplementary information February 2016.
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Bacillus subtilis DSM 28343 is compatible with the coccidiostats lasalocid A sodium, diclazuril,
monensin sodium, decoquinate, nicarbazin, robenidine hydrochloride, maduramicin ammonium and
halofuginone hydrobromide.
3.4. Post-market monitoring
The FEEDAP Panel considers that there is no need for speciﬁc requirements for a post-market
monitoring plan other than those established in the Feed Hygiene Regulation27 and good
manufacturing practice.
4. Conclusions
The bacterial species B. subtilis is considered by EFSA to be suitable for the QPS approach to safety
assessment. As the identity of the active agent has been established and the susceptibility to
antibiotics and lack of toxigenic potential have been demonstrated, the use of Bacillus subtilis
DSM 28343 can be presumed safe for the target species, consumers of products derived from animals
fed the additive and the environment.
Bacillus subtilis DSM 28343 is not an eye/skin irritant but should be considered as a potential
respiratory sensitiser. In the absence of data, no conclusion can be drawn on the skin sensitisation
potential.
Bacillus subtilis DSM 28343 at the proposed dose of 1 9 109 CFU/kg complete feedingstuffs has
the potential to improve performance of chickens for fattening.
B. subtilis DSM 28343 is compatible with the coccidiostats lasalocid A sodium, diclazuril, monensin
sodium, maduramicin ammonium, decoquinate, nicarbazin, robenidine hydrochloride and halofuginone
hydrobromide.
Documentation provided to EFSA
1) Bacillus subtilis DSM 28343. March 2015. Submitted by Lactosan GmbH & Co. KG.
2) Bacillus subtilis DSM 28343. March 2015. Supplementary information. February 2016.
Submitted by Lactosan GmbH & Co. KG.
3) Evaluation report of the European Union Reference Laboratory for Feed Additives on the
Methods(s) of Analysis for Bacillus subtilis DSM 28343.
4) Comments from Member States.
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Abbreviations
CFU colony-forming unit
EURL European Union Reference Laboratory
FEEDAP Panel EFSA Panel on Additives and Products or Substances used in Animal Feed
MIC minimum inhibitory concentration
OECD Organisation for Economic Co-operation and Development
QPS qualiﬁed presumption of safety
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Annex A – Executive Summary of the Evaluation Report of the European
Union Reference Laboratory for Feed Additives on the Method(s) of
Analysis for Bacillus subtilis DSM 283431
In the current application authorisation is sought under Article 4(1) for Bacillus subtilis DSM 28343
under the category/functional group 4(b) ‘zootechnical additives’/‘gut ﬂora stabilisers’, according to
Annex I of Regulation (EC) No 1831/2003. Speciﬁcally, authorisation is sought for the use of the feed
additive for chickens for fattening.
According to the Applicant, the feed additive contains as active substance the viable spores of non-
genetically modiﬁed Bacillus subtilis DSM 28343. The feed additive is to be marketed as cream-
coloured free-ﬂowing granules, containing a minimum Bacillus subtilis DSM 28343 concentration of
1 9 1010 Colony Forming Units (CFU)/g. The feed additive is intended to be used directly in
feedingstuffs or through premixtures at a minimum dose of 1 9 109 CFU/kg complete feedingstuffs.
For the identiﬁcation of Bacillus subtilis DSM 28343 the EURL recommends for ofﬁcial control Pulsed
Field Gel Electrophoresis (PFGE), a generally recognised standard methodology for genetic
identiﬁcation. This standard methodology for microbial identiﬁcation is currently being evaluated by the
CEN Technical Committee 327 to become a European Standard.
For the enumeration of Bacillus subtilis DSM 28343 in feed additive, premixtures and feedingstuffs
the Applicant submitted the ring-trial validated spread plate method EN 15784 which was already
evaluated by EURL in the frame of previous bacilli dossiers. Based on the performance characteristics
available the EURL recommends for ofﬁcial control the CEN method (EN 15784) for the enumeration of
Bacillus subtilis DSM 28343 in the feed additive, premixtures and feedingstuffs.
Further testing or validation of the methods to be performed through the consortium of National
Reference Laboratories as speciﬁed by Article 10 (Commission Regulation (EC) No 378/2005) is not
considered necessary.
1 The full report is available on the EURL website: https://ec.europa.eu/jrc/sites/default/ﬁles/ﬁnrep-fad-2015-0006-bacillus_
subtilis.pdf
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